-
公开(公告)号:US10689458B2
公开(公告)日:2020-06-23
申请号:US15356750
申请日:2016-11-21
Applicant: Pfizer Inc.
Inventor: Dangshe Ma , Frank Loganzo, Jr. , Kimberly Ann Marquette , Edmund Idris Graziani , Puja Sapra , Pavel Strop
Abstract: The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
-
2.ANTI-IL-13 RECEPTOR ALPHA 2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES 审中-公开
Title translation: 抗IL-13受体ALPHA 2抗体和抗体药物联合公开(公告)号:US20150266962A1
公开(公告)日:2015-09-24
申请号:US14439897
申请日:2013-10-30
Applicant: PFIZER INC.
Inventor: Dangshe Ma , Fang Jin , Lioudmila Gennadievna Tchistiakova , Puja Sapra
IPC: C07K16/28 , G01N33/574 , A61K47/48
CPC classification number: C07K16/2866 , A61K47/6803 , A61K47/6845 , A61K47/6849 , A61K47/6889 , A61K2039/505 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92 , C07K2317/94 , G01N33/57492 , G01N2333/7155
Abstract: Disclosed herein are anti-IL-13-Rα2 antibodies and antibody drug conjugates and methods for preparing and using the same.
Abstract translation: 本文公开了抗IL-13-Rα2抗体和抗体药物共轭物及其制备和使用方法。
-
公开(公告)号:US09828428B2
公开(公告)日:2017-11-28
申请号:US14439897
申请日:2013-10-30
Applicant: Pfizer Inc.
Inventor: Dangshe Ma , Fang Jin , Lioudmila Gennadievna Tchistiakova , Puja Sapra
IPC: C07K16/28 , A61K47/48 , G01N33/574 , A61K39/395 , A61K39/00
CPC classification number: C07K16/2866 , A61K47/6803 , A61K47/6845 , A61K47/6849 , A61K47/6889 , A61K2039/505 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92 , C07K2317/94 , G01N33/57492 , G01N2333/7155
Abstract: Disclosed herein are anti-IL-13-Rα2 antibodies and antibody drug conjugates and methods for preparing and using the same.
-
-